Plasma concentrations of curcumin in individuals using curcumin with adjuvants or lipid formulated curcumin supplements: a real world cohort
Kroon, M.; Berbee, J. K.; Majait, S.; Swart, E. L.; van Tellingen, O.; van Laarhoven, H. W. M.; Kemper, E. M.
Show abstract
The spice curcumin and its metabolites have been linked to many beneficial health effects. These effects have, thus far, not been duplicated in independent research most likely due to low plasma concentrations of curcumin. Despite the many reports, the publics interest in curcumin continues to grow and many people use curcumin in daily life. Moreover, companies seize the popularity of curcumin and claim that their formulations increase systemic expose of curcumin. In this independent study we determined the plasma concentration of curcumin after oral intake in daily life to determine if the systemic exposure is sufficient to achieve beneficial health effects. We used a validated HPLC-MS/MS assay to determine the plasma concentration of curcumin and its metabolites in 47 individuals (patient or healthy) using their own curcumin formulations. Through questionnaires, we assessed which other supplements and (self-)medication(s) were used. The concentrations of curcumin and its metabolites were analyzed in plasma samples collected just before and 1.5 h after curcumin intake. Each sample was pretreated with and without {beta}-glucuronidase to determine the levels of conjugated and unconjugated curcumin. After oral intake of the curcumin supplement, plasma concentrations of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin ranged between 2 and 4 nM. Use of adjuvants like piperine did not result in higher curcumin plasma concentrations. Adding {beta}-glucuronidase to the plasma sample increased curcumin plasma levels from below LLQ to 25.3 ng/mL, however still below any plasma concentration to which a beneficial health effect can be expected. The observed plasma concentration of unchanged curcumin remained several orders below the concentration of 2-100 g/mL used in in vitro studies. Therefore, our study confirms the low plasma levels of curcumin and indicates the need to be critical towards the claimed beneficial systemic health effects of current curcumin supplement use in daily life among patients and healthy individuals.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Combinatorial effects of Zingiber officinale and Citrus limon juices: Hypolipidemic and antioxidant insights from in vivo, in vitro, and in silico investigations 96%
- Clinical safety and pharmacokinetics of a novel oral niclosamide formulation compared with marketed niclosamide chewing tablets in healthy volunteers: a three-part randomized, double-blind, placebo-controlled trial 95%
- Interaction Of Quercetin And Epigallocatechin Gallate (Egcg) Aggregates With Pancreatic Lipase Under Simplified Intestinal Conditions 94%
Similar papers in this journal
- Pharmacokinetics of caffeine: A systematic analysis of reported data for application in metabolic phenotyping and liver function testing 93%
- CETP inhibitor evacetrapib enters mouse brain tissue 92%
- Anti-inflammatory properties of chemical probes in human whole blood: focus on prostaglandin E2 production 91%
Similar papers in this journal
- Promising protocol for in vivo experiments with betulin 95%
- Improved bioavailability of montelukast through a novel oral mucoadhesive film in humans and mice 95%
- Amorphous solid dispersions and the confounding effect of nanoparticles in in vitro dissolution and in vivo testing: Niclosamide as a case of study 93%
Similar papers in this journal
- A Strategy to Treat COVID-19 Disease with Targeted Delivery of Inhalable Liposomal Hydroxychloroquine: A Non-clinical Pharmacokinetic Study 92%
- Risk assessment of drug-induced Long QT Syndrome for some COVID-19 repurposed drugs 91%
- A long-acting GDF15 analog causes robust, sustained weight loss and reduction of food intake in an obese non-human primate model 88%
Similar papers in this journal
- Investigation on the interaction between nifedipine and ritonavir containing antivirus regimens: a physiologically-based pharmacokinetic/pharmacodynamic analysis 89%
- Anti-thyroid drug use during the first trimester of pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations 89%
- External validation of the predictive performance of population pharmacokinetic models for phenobarbital in pediatric patients 88%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.